The aim of Dua's study is to provide a psychometrically robust diagnostic assessment to improve management of patients with dysarthria in Jordan; this will be achieved by translating, extending and adapting the Frenchay Dysarthria Assessment (FDA-2) and testing its validity and reliability.
Click this link to view a poster about Dua's research: Improving the management of dysarthria in Jordan
